Education History

1. Bachelor of Science (Chemistry)Khon Kaen University. 2020

E-mail

p.bunmatham@gmail.com

RESEARCH EXPERIENCE

1. A randomized, blinded, positive control phase 1a trial to evaluate the safety and immunogenicity of a SARS-CoV-2 mRNA chimera vaccine (RQ3013) in healthy adults aged 18-59 years

2. A Phase III, Parallel Group, Prospective, Randomized, Doubleblind, Activecontrolled, Two-arm Study to Evaluate the Immunogenicity, Safety, andTolerability of the SARS-CoV-2 Vaccine Candidate MVC-COV1901Compared to AZD1222 Vaccine in Adult Volunteers of 18 Years and Above